Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B17 | O75795 | 2/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.31 |
| ▸ | DRD1 | P21728 | 2/20 | 0.31 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.30 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.30 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14543582 | 0.82 | UGT2B17 (0.44) | UGT2B17SIGMAR1ALDH1A1 | |
| SCHEMBL17278091 | 0.80 | HTR2C (0.44) | UGT2B17 | |
| SCHEMBL20368645 | 0.80 | HTR2A (0.44) | UGT2B17CYP2A6CYP2A13ALDH1A1TSHR | |
| SCHEMBL1508636 | 0.78 | UGT2B17 (0.82) | UGT2B17SIGMAR1KDM4CDRD2DRD1 | |
| SCHEMBL13114074 | 0.78 | UGT2B17 (0.55) | UGT2B17SIGMAR1KDM4CDRD2DRD1 | |
| SCHEMBL20368640 | 0.75 | UGT2B17 (0.51) | UGT2B17SIGMAR1KDM4CRAPGEF4PSMB5 | |
| SCHEMBL20078381 | 0.75 | UGT2B17 (0.51) | UGT2B17SIGMAR1KDM4CALDH1A1DRD2 | |
| SCHEMBL30863839 | 0.72 | UGT2B17 (0.32) | UGT2B17 | |
| SCHEMBL30863838 | 0.72 | UGT2B17 (0.32) | UGT2B17 | |
| SCHEMBL19827773 | 0.72 | UGT2B17 (0.41) | UGT2B17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8895789-B2 | Fuel composition for use in gasoline engines | SHELL OIL COMPANY (US) | 2014-11-25 | — | — | US | claimed |
| US-20230219907-A1 | CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES | SITRYX THERAPEUTICS LIMITED (GB) | 2023-07-13 | — | — | US | disclosed |
| US-8895789-B2 | Fuel composition for use in gasoline engines | SHELL OIL COMPANY (US) | 2014-11-25 | — | — | US | disclosed |
| US-8876920-B2 | Fuel composition for use in gasoline engines | SHELL OIL COMPANY (US) | 2014-11-04 | — | — | US | disclosed |
| EP-2367907-B1 | FUEL COMPOSITION FOR USE IN GASOLINE ENGINES | SHELL INT RESEARCH (NL) | 2013-04-24 | — | — | EP | disclosed |
| EP-2367908-B1 | FUEL COMPOSITION FOR USE IN GASOLINE ENGINES | SHELL INT RESEARCH (NL) | 2013-02-20 | — | — | EP | disclosed |
| US-20120101316-A1 | METHOD FOR THE PREPARATION OF A FUEL COMPOSITION FOR USE IN GASOLINE ENGINES AND BLENDING COMPONENT | SHELL OIL COMPANY | 2012-04-26 | — | — | US | disclosed |
| US-20120022304-A1 | FUEL COMPOSITION FOR USE IN GASOLINE ENGINES | SHELL OIL COMPANY (US) | 2012-01-26 | — | — | US | disclosed |
| EP-2367908-A1 | FUEL COMPOSITION FOR USE IN GASOLINE ENGINES | Shell Internationale Research Maatschappij B.V. (NL) | 2011-09-28 | — | — | EP | disclosed |
| EP-2367906-A1 | METHOD FOR THE PREPARATION OF A FUEL COMPOSITION FOR USE IN GASOLINE ENGINES AND BLENDING COMPONENT | Shell Internationale Research Maatschappij B.V. (NL) | 2011-09-28 | — | — | EP | disclosed |
| EP-2367907-A1 | FUEL COMPOSITION FOR USE IN GASOLINE ENGINES | Shell Internationale Research Maatschappij B.V. (NL) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010066879-A1 | FUEL COMPOSITION FOR USE IN GASOLINE ENGINES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2010-06-17 | — | — | WO | disclosed |
| WO-2010066876-A1 | FUEL COMPOSITION FOR USE IN GASOLINE ENGINES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2010-06-17 | — | — | WO | disclosed |
| WO-2010066881-A1 | METHOD FOR THE PREPARATION OF A FUEL COMPOSITION FOR USE IN GASOLINE ENGINES AND BLENDING COMPONENT | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219907-A1 | CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES | CPA2, RO60, C5AR1 | UGT2B17 2424/4885SIGMAR1 2701/4885KDM4C 1168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.